Clinical Trial

VIZ ACCESS HCM - Multi-Site Registry

Recruiting
View on ClinicalTrials.gov →
Summary
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-01.
Trial Details
NCT Number NCT07103057
Lead Sponsor Viz.ai, Inc.
Conditions Hypertrophic Cardiomyopathy
Enrollment 500 participants
Start Date 2025-06-13
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-17